Results 81 to 90 of about 528,622 (127)

CytoSorb haemoadsorption in critically ill children: a multicentre observational study on feasibility, safety, and outcomes, the CYTOPED study

Annals of Intensive Care
Introduction: CytoSorb® is a cartridge for the adsorption of inflammatory mediators, bilirubin, myoglobin and other xenobiotics, directly from the blood stream.
Gabriella Bottari, Stefania Bianzina, Anna Tessari, Monica Fae, Sara Giovannini, Stefano Scollo, Elena Caporossi, Fabio Paglialonga, Pietro Lonardi, Raffaella Sagredini, Alessandro Simonini, Fabio Caramelli, Germana Longo, Corrado Cecchetti, Andrea Moscatelli, Isabella Guzzo   +15 more
doaj   +1 more source

Extracorporeal Hemadsorption versus Glucocorticoids during Cardiopulmonary Bypass: A Prospective, Randomized, Controlled Trial

Cardiovascular Therapeutics, 2020
Extracorporeal hemadsorption may reduce inflammatory reaction in cardiopulmonary bypass (CPB) surgery. Glucocorticoids have been used during open-heart surgery for alleviation of systemic inflammation after CPB.
Gordana Taleska Stupica, Maja Sostaric, Marija Bozhinovska, Lea Rupert, Zoran Bosnic, Ales Jerin, Alojz Ihan, Tomislav Klokocovnik, Matej Podbregar   +8 more
doaj   +1 more source

Hemoperfusion Combined With Continuous Renal Replacement Therapy in the Management of ARDS COVID‐19 Patients: A Quasi‐Experimental Study

Health Science Reports, Volume 8, Issue 4, April 2025.
ABSTRACT Background and Aims Critically ill patients in COVID‐19 to the intensive care unit (ICU) may develop multiple organ dysfunction syndrome, with some requiring extracorporeal organ support. This study aimed to assess the effects of combined CytoSorb hemoperfusion (HP) and continuous renal replacement therapy (CRRT) on the improvement of the ...
Seyed MohammadReza Hashemian, Ameneh Jafari, Batoul Khoundabi, Hamidreza Jamaati, Payam Rahimi   +4 more
wiley   +1 more source

CytoResc – “CytoSorb” Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial

Trials, 2020
Objectives Approximately 8 - 10 % of COVID-19 patients present with a serious clinical course and need for hospitalization, 8% of hospitalized patients need ICU-treatment. Currently, no causal therapy is available and treatment is purely supportive.
Helena Stockmann, Theresa Keller, Stefan Büttner, Achim Jörres, Detlef Kindgen-Milles, Julius Valentin Kunz, Josef Leebmann, Claudia Spies, Karl Träger, Sascha Treskatsch, Alexander Uhrig, Carsten Willam, Philipp Enghard, Torsten Slowinski, for the CytoResc Trial Investigators   +14 more
doaj   +1 more source

Simultaneous Treatment of Two Severe Acute Intoxication and Acute Kidney Injury

Seminars in Dialysis, Volume 38, Issue 2, Page 152-155, March/April 2025.
ABSTRACT Extracorporeal therapies could be required for treatment of life‐threatening severe acute intoxication. We present the case of an 82‐year‐old patient admitted to our Nephrology Unit because of metformin‐associated lactic acidosis (MALA) and acute kidney injury (AKI stage III AKIN criteria).
Fulvia Zappulo, Laura Martano, Ines Ullo, Veronica Catalano, Sara Donini, Anna Scrivo, Anna Laura Croci Chiocchini, Gaetano La Manna   +7 more
wiley   +1 more source

Clindamycin clearance during Cytosorb hemoadsorption: A case report and pharmacokinetic study.

, 2019
Panton-Valentine leucocidin producing methicillin-resistant Staphylococcus aureus infections are rare but associated with very high mortality rates.
Poli, E.C., André, P., Ferry, T., Simoni, C., Buclin, T., Perez, M.H., Longchamp, D., Schneider, A.G., Ferry T, Simoni C, Perez MH, Buclin T, Longchamp D, Schneider AG, Poli EC, André P   +15 more
core   +1 more source

The Revival of Sorbents in Chronic Dialysis Treatment

Seminars in Dialysis, Volume 38, Issue 1, Page 54-61, January/February 2025.
ABSTRACT Interest in the use of sorbents in chronic dialysis treatment has undergone a revival in the last decades, for which two major factors are responsible. The first is the potential of sorbents as adjunct therapy for the removal of substances that are difficult to remove by conventional dialysis therapies.
Jeroen Peter Kooman
wiley   +1 more source

Artificial Liver Support with CytoSorb and MARS in Liver Failure: A Retrospective Propensity Matched Analysis

, 2023
Background: Liver failure represents a life-threatening organ dysfunction with liver transplantation as the only proven curable therapy to date. Liver assist devices have been extensively researched to either bridge such patients to transplantation or ...
Alexandra Marcu, Mihaela Roxana Olita, Corina David, Mariana Mihaila, Mihai Popescu, Dana Tomescu   +5 more
core   +1 more source

Terapia de hemadsorción perioperatoria en endocarditis infecciosa: revisión sistemática y metaanálisis

Cirugía Cardiovascular
Resumen: La endocarditis infecciosa (EI) es una enfermedad sistémica con afectación multiorgánica. Se trata de una entidad grave, que con frecuencia requiere de tratamiento quirúrgico, a pesar del cual las tasas de mortalidad pueden ser elevadas debido a
Elio Martín Gutiérrez, Laura Castillo Pardo, Pasquale Maiorano, Bárbara Oujo González, Gregorio Laguna Núñez, José Manuel Martínez Comendador, Javier Gualis Cardona, Mario Castaño Ruiz   +7 more
doaj   +1 more source

Venlafaxine Intoxication with Development of Takotsubo Cardiomyopathy: Successful Use of Extracorporeal Life Support, Intravenous Lipid Emulsion and Cytosorb^®

, 2017
We describe a young patient who ingested 18 g (240 times the daily therapeutic dose) of venlafaxine in a suicide attempt. She developed severe cardiomyopathy in a takotsubo distribution causing cardiogenic shock and multi-organ dysfunction syndrome ...
Michael Zoller, Lorenz Frey, Felix Kur, Matthias Angstwurm, Ines Schroeder   +4 more
core   +1 more source